Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dequalinium chloride vaginal tablets versus oral metronidazole for bacterial vaginosis
2020-002489-15Phase 4Terminated
- Sponsor
- Medinova AG
- Start
- Dec 2020
- Modality
- Small Molecules, Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in bacterial vaginosis (BV) comparing Fluomizin arm with Metronidazole arm (2 arms). Primary endpoint: Clinical cure rate at C1. Started Dec 2020; status: terminated.
02
Drugs
dequaliniummetronidazole
03
Conditions
bacterial vaginosis (BV)
Beyond the preview
Go deeper on 2020-002489-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-002489-15.